Laddar...
Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients
Methotrexate (MTX) is known as a first-line synthetic disease-modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). Although the risk of LPD development increases by RA inflammation itself, observation of spontaneous regression of LPD after MTX discontinuation lead to...
Sparad:
| I publikationen: | J Clin Exp Hematop |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
JSLRT
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6954173/ https://ncbi.nlm.nih.gov/pubmed/31866617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.19028 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|